sk

403 posts

sk banner
sk

sk

@compchemm

Computational Structural Biologist |

Katılım Nisan 2017
452 Takip Edilen560 Takipçiler
sk retweetledi
FabricagenDOTai
FabricagenDOTai@FabricagenDOTai·
Our JAX Fv folder was observed to have near CDRH3 structural recovery parity with IgFold using our internal leak free corpus We benchmarked against our internal hold outs and their original set rederived 0.1 A different right now 2.908 vs 2.812 I am going to push it further with a different corpus xtal:synth sampling ratio and push for more steps Either way we will share this tool and the sister jax tool we built, ablanx, this week. Weight code benchmarking data and permissive licensing. Jaxfvld is lightweight and is sequence differentiable, allowing it to be used in interesting applications. Ablanx is a faithful jax implementation of Ablang2 useful for differentiable antibody workflows. We needed it so we could recreate an IgFold like repo differentiable to sequence. So we built it. And we are shipping it to you. We will drop a technical document on ablanx tomorrow with code and weights. Jaxfvld will follow after some final benchmarking and testing. Lastly, a developability focused composition of the two, called sift, will be available for testing via a web portal as soon as I can finish everything. Once the code and weights are up please test it hard and let me know what you think!
English
0
3
23
6.5K
sk
sk@compchemm·
Mid of the year! i read some 2-3 papers with somewhat similar approach. So Binder design is now becoming Master's project(thesis). But designing proteins that can bind small molecules is not hard anymore. The secret sauce is ligandmpnn.
sk tweet media
English
2
10
126
8.4K
sk
sk@compchemm·
Progress without safeguards is reckless; safeguards without progress is stagnation. We should aim for neither.
English
0
0
1
175
sk
sk@compchemm·
Vilya-1 not only design incredibly lethal toxins(alpha conotoxin/amanatin), with "sub-angstrom accuracy", but can also optimize its "membrane permeability", with "non-canonical (unnatural) amino acids" - structurally fully stealth toxins. nature.com/articles/d4158…
Biology+AI Daily@BiologyAIDaily

Vilya-1: An all-atom foundation model for macrocycle structure prediction and design 1. Vilya-1 is an all-atom diffusion-based foundation model aimed at a core bottleneck in macrocycle drug discovery: reliably sampling biologically relevant low-energy conformations across arbitrary, synthetically accessible chemistries (not just canonical peptides). 2. On 66 cyclic-peptide X-ray structures, Vilya-1 samples a near-native ring conformation (ring RMSD < 1 Å) in 89.2% of cases, vs 37.6% (Prime-MCS), 34.5% (RDKit ETKDGv3), ~15% (Boltz-2 / RF3), and 4.8–17.0% for several deep-learning conformer generators (TorDiff/LoQI/ETFlow). 3. The model generalizes across macrocycle classes/topologies, including disulfide-stapled peptides, sidechain-to-sidechain cyclizations, tail-to-sidechain cyclizations, and non-peptidic macrocycles (e.g., macrolides/polyketides). Reported examples include FK506, Sanglifehrin A, Lorlatinib, α-amanitin, and others with sub-Å ring accuracy. 4. A key design choice is a uniform heavy-atom representation that does not label “peptide vs small molecule,” enabling one architecture to cover mixed peptidic/non-peptidic scaffolds and even standard small molecules—addressing a common failure mode of residue-tokenized or protein-centric co-folding approaches on non-canonical chemistry. 5. Architecture-wise, Vilya-1 uses a single unified transformer for both representation learning and the diffusion process (rather than separate trunk + diffusion modules), with triangle attention/multiplication and pair-bias attention; inputs include atom scalar features, pairwise features, and atom vector features, and outputs 3D coordinates directly. 6. Training combines heterogeneous structural sources: public small-molecule and peptide crystal structures plus computationally generated macrocyclic peptide structures. Losses include diffusion coordinate reconstruction, a distogram auxiliary loss, and an explicit chirality loss to reduce stereochemical errors. 7. For receptor-bound conformations of macrocycles (240 PDB-derived ligands), Vilya-1 reaches 93% success (ring RMSD < 1 Å) despite not being trained on these structures; the paper notes that many entries in this benchmark appear in Boltz-2’s training set, highlighting Vilya-1’s emphasis on generalization rather than overlap. 8. The work adds a confidence model (fine-tuned from the conformer generator) to rank sampled conformers. On top-1 selection, confidence ranking improves success by 21.1% over random, comparable to MLIP energy-based scoring (21.9%), while being far cheaper computationally (~40 ms per conformer vs ~6120 ms for MLIP scoring with minimization). 9. Vilya-1 is also fine-tuned for multi-task property prediction from generated conformers (permeability via PAMPA/MDCK, chromatographic LogD, kinetic solubility, plus computed 3D polar surface area). Evaluation uses enrichment factor (top 10%) and includes time-based splits for internal data and scaffold splits for external datasets; structure-pretraining generally improves transfer, especially in “hit-series” settings where subtle conformational differences among close analogs drive permeability. 10. For design, Vilya-1 supports ligand-centric conformational landscape analysis: generating ensembles, scoring with MLIPs, and computing Pnear to quantify preorganization. Across three campaigns, prioritizing by Pnear enriches binders (Kd ≤ 50 µM) without modeling the target explicitly—suggesting conformational preorganization alone can be a useful, target-agnostic filter. 11. The paper also demonstrates discrete multi-objective optimization to “miniaturize” larger macrocycles by scaffolding key binding motifs into smaller rings (e.g., shrinking 13–14mers to 7mers) while optimizing predicted developability (higher permeability/hydrophobicity, lower solvent-accessible polar surface area), and it explicitly supports complex cyclization chemistries used in display technologies (thioether, γ-lactam, i,i+7 staples). 📜Paper: arxiv.org/abs/2607.09998 #ComputationalChemistry #Macrocycles #CyclicPeptides #DiffusionModels #MolecularModeling #DrugDiscovery #Cheminformatics #StructuralBiology #MachineLearning

English
1
5
28
6.5K
sk retweetledi
Peldom Zhang
Peldom Zhang@PeldomZ·
Design de novo sensor from scratch? Introducing ProBuilder: A backbone generative algorithm for designing ligand-induced binders. We report de novo sensors for serotonin, zinc, etc. A versatile framework for future sensor development. preprint👇 biorxiv.org/content/10.648…
Peldom Zhang tweet mediaPeldom Zhang tweet media
English
5
38
178
9.9K
sk
sk@compchemm·
Open Models - beat AlphaFold3 "AlphaFold3 is no longer the best model" is a scope error — AF3's claim is joint generality across "proteins, nucleic acids, ligands, ions and modified residues".
sk tweet mediask tweet mediask tweet mediask tweet media
English
4
9
65
9.4K
sk retweetledi
Will Hua
Will Hua@itswillhua·
OpenDDE is not a simple reproduction of IsoDDE. We just want to build an open-source ecosystem towards REAL Drug Discovery Engine. The core is co-folding, but what's next? The next-preview release is about design.
Will Hua tweet media
English
4
17
136
24.3K
sk
sk@compchemm·
@0xCF88 Here 😅
sk tweet mediask tweet mediask tweet media
English
0
0
2
78
sk
sk@compchemm·
David Baker & Veesler labs "building viruses - Institute for Protein Design (IPD) -Two new Nature papers - "building viruses, at University of Washington" if you believe the headlines. What they've actually done is more interesting than that. ullahsamee.substack.com/p/david-baker-…
sk tweet media
English
1
36
169
12K
sk
sk@compchemm·
@0xCF88 Use prompt: "modern Davinci sketch style" and then from there onwards you can add text, remove anything you don't need etc.
English
1
0
1
102
sk
sk@compchemm·
@0xCF88 Using gemini3.5 extended version
English
1
0
1
399
Gio
Gio@johnny_83·
@compchemm Unless we know which "blind protein–ligand test set" we're talking about, that plot is essentially meaningless.
English
1
0
0
217
sk
sk@compchemm·
Protenix-v2 weights available now😍 apples to apples comparison from Lucas Nivon post. Protenix ahead of all; AF3, Boltz, OF3-p2 on a blind test set of protein/ligand. So for Co-Folding use minimum Protenix-v2 huggingface.co/TMF001/proteni…
sk tweet mediask tweet media
English
5
14
101
8K
GAMA Miguel Angel 🐦‍⬛🔑
It was very hard to choose only 11 people, but here is my current lineup of proteinologists. What's yours? 🧐
GAMA Miguel Angel 🐦‍⬛🔑 tweet media
Leonardo V. Castorina@DrLeucine

@miangoar love the idea. Since it’s the World Cup, I decided to make my own protein design lineup. Rules: 11 scientists max. No (direct) supervisors.

English
1
2
47
24.7K
sk
sk@compchemm·
@btnaughton "if the user experienced irritation, they could stop using it—it doesn't persist" works well for a flat, open surface like skin. Nose is structurally complex series of tunnels connected to chambers (sinuses, ears), local tissue swelling creates immediate mechanical blockages.
sk tweet media
English
0
0
0
35
sk
sk@compchemm·
@btnaughton Because these blood vessels are highly superficial and epithelial barrier is thin. So even if your peptide doesn't penetrate cells (remaining extracellular), it is highly likely to slip between the cells and pass directly into rich vascular network, entering the bloodstream.
English
1
0
0
48
GAMA Miguel Angel 🐦‍⬛🔑
Listen to me Anthropic (@AnthropicAI @ClaudeAI @DarioAmodei): If you want to build a "ClaudeFold" together with @JohnJumperSci and enter the world of AI-driven protein design, you should hire people like these great leaders (as well as the other individuals on these lists).
GAMA Miguel Angel 🐦‍⬛🔑@miangoar

It feels like they're announcing a festival along with the headliners. Here is a personal list of researchers in AI-based protein science whose work I really admire, they’re incredibly creative! And a longer list of other colleagues working in the field x.com/miangoar/statu…

English
1
0
12
3.3K